Siemens Healthcare

Devices & Diagnostics

Siemens’ PETNET subsidiary agrees to use Lilly tracer

Siemens’ positron emission tomography business subsidiary — PETNET Solutions — agreed to manufacture and distribute Eli Lilly‘s (NYSE:LLY)  molecular imaging agent currently under review by the U.S. Food and Drug Administration. Florbetapir, a labeled tracer for imaging-amyloid aggregates in the human brain by positron emission tomography, is under regulatory review by the FDA. If approved, […]

Devices & Diagnostics

Siemens Healthcare acquires MobileMD

Siemens Healthcare (NYSE:SI) has agreed to acquire MobileMD, a Yardley, Pennsylvania health IT company that provides a cloud-based platform between physician practices and hospitals that translates and normalizes data from different health IT systems. It is Siemens Healthcare’s first health IT acquisition, a spokesman for the company said. MobileMD’s system allows physician practices to maintain […]

presented by